Franklin C. Harwood

Imatinib Mesylate Is a Potent Inhibitor of the ABCG2 (BCRP) Transporter and Reverses Resistance to Topotecan and SN-38 <b> <i>in Vitro</i> </b>

Peter J. Houghton, Glen S. Germain, Franklin C. Harwood et al. · Cancer Research · 2004 · 319 citations · Full text

Biochemical correlates of mTOR inhibition by the rapamycin ester CCI-779 and tumor growth inhibition.

Lorina Dudkin, Michael B. Dilling, Pamela J. Cheshire et al. · PubMed · 2001 · 232 citations

Chemoprevention Strategy, Cancer Biology, Tumor Biology +19

Sustained Activation of the JNK Cascade and Rapamycin-Induced Apoptosis Are Suppressed by p53/p21Cip1

Shile Huang, Lili Shu, Michael B. Dilling et al. · Molecular Cell · 2003 · 220 citations · Full text

Signal Transduction, Signaling Pathway, Cell Regulation +10

Gefitinib Enhances the Antitumor Activity and Oral Bioavailability of Irinotecan in Mice

Clinton F. Stewart, Markos Leggas, John D. Schuetz et al. · Cancer Research · 2004 · 199 citations

ETV7 is an essential component of a rapamycin-insensitive mTOR complex in cancer

Franklin C. Harwood, Ramon I. Klein Geltink, Brendan P. O’Hara et al. · Science Advances · 2018 · 130 citations · Full text